Medication info
Pioran Tablet 30 mg (Pioglitazone Hydrochloride)

Pioran Tablet 30 mg (Pioglitazone Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Pioglitazone Hydrochloride›33.06mg / 1 tablet
Manufacturer / importer
You&Life Science Co., Ltd.
Appearance
White round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202001690 · Approved 2020.03.11

Summary

Main use
Improvement of blood glucose control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
Administer orally once daily, regardless of meals. If glycemic control does not worsen in patients with diabetes, treatment should be continued for an appropriate period (at least 3 months) to evaluate changes in glycated hemoglobin. 1. Monotherapy In patients whose blood glucose is not adequately controlled with diet and exercise, this medication may be initiated as monotherapy at 15 mg of pioglitazone once daily. If the initial dose does not provide sufficient efficacy, the dose may be increased to 30 mg once daily. 2. Combination therapy 1) Sulfonylurea: The initial dose is 15 mg once daily. The current sulfonylurea medication may be continued at the same dosage regimen. If symptoms of hypoglycemia occur, the dose of the sulfonylurea should be reduced. 2) Metformin: The initial dose is 15 mg once daily. Current metformin may be continued at the same dosage regimen. 3) Insulin: Administer 15 mg once daily. The current insulin dose may be maintained when starting combination therapy. If symptoms of hypoglycemia occur or plasma glucose concentration decreases to 100 mg/dL or below, the insulin dose may be reduced by 10 ~ 25 %. Subsequent dose adjustments should be made individually according to glycemic control. Maximum recommended dose: For monotherapy or combination therapy with a sulfonylurea, metformin, or insulin, doses exceeding 30 mg once daily are not recommended. Dose adjustment is not recommended in patients with renal impairment.
Child dose
Use is not recommended in children under 18 years of age because there is no experience with its use in this age group.

Ingredients

Manufacturer
You&Life Science Co., Ltd.

Efficacy & effects

Improvement of blood glucose control in type 2 diabetes mellitus

  • Type 2 Diabetes
View approved original text

This medication is used to help control blood sugar in patients with Type 2 Diabetes in conjunction with diet and exercise. It can be administered alone, or in combination with other oral hypoglycemic agents if blood sugar improvement is difficult. Additionally, patients should receive nutritional counseling and, if necessary, practice weight loss and exercise, as such lifestyle changes significantly enhance the effectiveness of medication and help maintain long-term blood sugar control. Therefore, this medication is used to improve blood sugar control in patients with Type 2 Diabetes.

How to take

Adult dose

Administer orally once daily, regardless of meals. If glycemic control does not worsen in patients with diabetes, treatment should be continued for an appropriate period (at least 3 months) to evaluate changes in glycated hemoglobin. 1. Monotherapy In patients whose blood glucose is not adequately controlled with diet and exercise, this medication may be initiated as monotherapy at 15 mg of pioglitazone once daily. If the initial dose does not provide sufficient efficacy, the dose may be increased to 30 mg once daily. 2. Combination therapy 1) Sulfonylurea: The initial dose is 15 mg once daily. The current sulfonylurea medication may be continued at the same dosage regimen. If symptoms of hypoglycemia occur, the dose of the sulfonylurea should be reduced. 2) Metformin: The initial dose is 15 mg once daily. Current metformin may be continued at the same dosage regimen. 3) Insulin: Administer 15 mg once daily. The current insulin dose may be maintained when starting combination therapy. If symptoms of hypoglycemia occur or plasma glucose concentration decreases to 100 mg/dL or below, the insulin dose may be reduced by 10 ~ 25 %. Subsequent dose adjustments should be made individually according to glycemic control. Maximum recommended dose: For monotherapy or combination therapy with a sulfonylurea, metformin, or insulin, doses exceeding 30 mg once daily are not recommended. Dose adjustment is not recommended in patients with renal impairment.

Child dose

Use is not recommended in children under 18 years of age because there is no experience with its use in this age group.

Precautions

This medication helps control blood sugar in patients with Type 2 Diabetes and works in conjunction with insulin to lower blood sugar levels. During the use of this medication, there is a risk that heart failure, a condition of decreased heart function, may occur or worsen, so if symptoms such as sudden weight gain or difficulty breathing and swelling appear, one should immediately notify their doctor. Patients with a history of heart failure should not use this medication, and those with heart disease should use it very cautiously. This medication can cause fluid retention, which may worsen edema or heart failure, so immediate consultation with healthcare providers is necessary if symptoms like swelling or difficulty breathing arise. Furthermore, this medication should not be administered to patients with bladder cancer or a history of bladder cancer, and if symptoms like hematuria or urinary problems occur during treatment, one should immediately notify their doctor. Patients with severely impaired liver or kidney function should not take this medication, and if symptoms of liver dysfunction (fatigue, loss of appetite, abdominal pain, jaundice, etc.) arise, one should seek medical evaluation immediately. Since this medication carries a risk of hypoglycemia, care should be taken when taking it in combination with insulin or other hypoglycemic agents, and dosage adjustment may be necessary as needed. Pre-menopausal women may experience enhanced ovulation with this medication, leading to an increased possibility of pregnancy, so appropriate contraceptive methods should be used. Elderly patients, particularly those over 75 years old, may have an increased risk of side effects when taking this medication, so caution is warranted. Regular monitoring of blood sugar and liver function tests is required during the use of this medication, and if weight gain or edema occurs, healthcare providers should be notified. While overdose may not present specific symptoms, appropriate treatment is necessary based on symptoms. This medication has not been proven safe and effective for children, so it should not be used in this population. Finally, this medication should be stored out of the reach of children and kept in its original container.

Side effects

Congestive heart failure, excessive and rapid weight changes, shortness of breath, edema, fluid retention, swelling, headache, sinusitis, myalgia, pharyngitis, abdominal distention, weight gain, hypoglycemia, upper respiratory infection, urinary tract infection, low back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular predisposition, worsening of congestive heart failure, emergency room visits due to congestive heart failure, liver failure, diabetic macular edema accompanied by decreased vision, increased blood sugar, loss of appetite, constipation, upper abdominal pain, chest discomfort, fatigue, weakness, dyspepsia, nausea, shortness of breath, itching, chest discomfort, tremors, chills, gastrointestinal disorders, abdominal pain, epigastric discomfort, numbness, muscle stiffness, head discomfort, increased liver enzymes, worsening of liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, increased serum creatinine, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, heart failure, fractures, visible hematuria, urination disorders, urgency in urination

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a container that is protected from light and air, and avoid damp places. Additionally, to maintain the drug's effectiveness, it is best to store it at a temperature between 15-30 degrees Celsius, preferably around 25 degrees in a cool place.

Appearance and packaging

Appearance

White round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.